Intrinsiqs

Is The Joint Corp. overvalued?

The Joint Corp. (JYNT) looks overvalued — trading about 42% above its fair value.

Overvalued
Current price $7.75 Fair value $4.50
Price
$7.75
Fair value
$4.50
Current P/E
77.5
Normal P/E
45.0
Market cap
$110.5M
Dividend yield
0.0%
Return on equity
22.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares JYNT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co., Inc.RHHBY Roche Holding AGUNH UnitedHealth Group Incorporated